LGBT Cancer Project

Therapeutic Areas: Oncology | Nephrology | Family Medicine

Kidney Cancer Clinical Trials

A listing of Kidney Cancer medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

 

Alabama

Birmingham Alabama 35294

Patients are needed to participate in a clinical research study evaluating Avelumab and Sunitinib for the treatment of Clear-cell Renal Cell Carcinoma, RCC, Kidney Cancer or Clear-cell Kidney Carcinoma

Arizona

Scottsdale Arizona 85258

Patients are needed to participate in a clinical research study evaluating CC-486 (Oral Azacitidine) and Vidaza

Scottsdale Arizona 85259

Patients are needed to participate in a clinical research study evaluating CC-486 (Oral Azacitidine) and Vidaza

Scottsdale Arizona 85258

Patients are needed to participate in a clinical research study evaluating CDX-014

Tucson Arizona 85719

A clinical research study of CPI-444 and CPI-444 + atezolizumab

California

Los Agneles California 90033

A Phase 1 clinical study for patients with Neoplasms, Advanced Solid Tumors

Los Angeles California 90095

A clinical research study of CPI-444 and CPI-444 + atezolizumab

Los Angeles California 90048

A Phase 1 clinical study for patients using PART 1: PT2385 Tablets and PART 2: PT2385 Tablets in combination with nivolumab

Los Angeles California 90095-6984

A Phase 1 clinical study for patients with Neoplasms, Advanced Solid Tumors

Los Angeles California 90024

A Phase 1 clinical study for patients with Neoplasms, Advanced Solid Tumors

Los Angeles California 90095

A Phase 1 clinical study for patients with Neoplasms, Advanced Solid Tumors

Los Angeles California 90095

A Phase 1 clinical study for patients with Neoplasms, Advanced Solid Tumors

Los Angeles California 90025

A Phase 1 clinical study for patients with Neoplasms, Advanced Solid Tumors

Los Angeles California 90033

A Phase 1 clinical study for patients with Neoplasms, Advanced Solid Tumors

Los Angeles California 90033

A Phase 1 clinical study for patients with Neoplasms, Advanced Solid Tumors

Los Angeles California 90033

Patients are needed to participate in a clinical research study evaluating CDX-014

Newport Beach California 92663

A Phase 1 clinical study for patients with Neoplasms, Advanced Solid Tumors

San Francisco California 94143

A clinical research study of CPI-444 and CPI-444 + atezolizumab

Santa Monica California 90403

A Phase 1 clinical study for patients with Neoplasms, Advanced Solid Tumors

Santa Monica California 90404

A Phase 1 clinical study for patients with Neoplasms, Advanced Solid Tumors

Santa Monica California 90404

A Phase 1 clinical study for patients with Neoplasms, Advanced Solid Tumors

Stanford California 94305

A clinical research study of CPI-444 and CPI-444 + atezolizumab

Colorado

Aurora Colorado 80045

A clinical research study of CPI-444 and CPI-444 + atezolizumab

Aurora Colorado 80045

A Phase 1 clinical study for patients using PART 1: PT2385 Tablets and PART 2: PT2385 Tablets in combination with nivolumab

Connecticut

Farmington Connecticut 06030

A Phase 1 clinical study for patients with Neoplasms, Advanced Solid Tumors

Farmington Connecticut 06030-2205

A Phase 1 clinical study for patients with Neoplasms, Advanced Solid Tumors

New Haven Connecticut 06510

A clinical research study of CPI-444 and CPI-444 + atezolizumab

New Haven Connecticut 06510

A Phase 1 clinical study for patients using PART 1: PT2385 Tablets and PART 2: PT2385 Tablets in combination with nivolumab

District of Columbia

Washington District of Columbia 20057

A clinical research study of CPI-444 and CPI-444 + atezolizumab

Florida

Miami Florida 33136

A Phase 1 clinical study for patients using PART 1: PT2385 Tablets and PART 2: PT2385 Tablets in combination with nivolumab

UPDATED

Tampa Florida 33612

A clinical research study of Pembrolizumab and Interleukin-2 for the treatment of Kidney Cancer

Tampa Florida 33612

A Phase 1 clinical study for patients with Neoplasms, Advanced Solid Tumors

Georgia

Atlanta Georgia 30322

A clinical research study of CPI-444 and CPI-444 + atezolizumab

Atlanta Georgia 30322

A Phase 1 clinical study for patients using PART 1: PT2385 Tablets and PART 2: PT2385 Tablets in combination with nivolumab

Illinois

Chicago Illinois 60637

A clinical research study of CPI-444 and CPI-444 + atezolizumab

Chicago Illinois 60612

A clinical research study of CPI-444 and CPI-444 + atezolizumab

Chicago Illinois 60612

A Phase 1 clinical study for patients using PART 1: PT2385 Tablets and PART 2: PT2385 Tablets in combination with nivolumab

Indiana

Indianapolis Indiana 46202

A clinical research study of CPI-444 and CPI-444 + atezolizumab

Indianapolis Indiana 46202

A Phase 1 clinical study for patients using PART 1: PT2385 Tablets and PART 2: PT2385 Tablets in combination with nivolumab

Iowa

Iowa City Iowa 52242

Patients are needed to participate in a clinical research study evaluating CC-486 (Oral Azacitidine) and Vidaza

Maryland

Baltimore Maryland 21287

A clinical research study of CPI-444 and CPI-444 + atezolizumab

Baltimore Maryland 21287

A clinical research study of Nivolumab for the treatment of Clear Cell Renal Cell Carcinoma, Non-metastatic Stage II-IV

Baltimore Maryland 21201

A Phase 1 clinical study for patients using PART 1: PT2385 Tablets and PART 2: PT2385 Tablets in combination with nivolumab

Massachusetts

Boston Massachusetts 02114

A clinical research study of STM 434 and Liposomal doxorubicin for the treatment of Ovarian Cancer, Fallopian Tube Cancer, Endometrial Cancer or Solid Tumors

Boston Massachusetts 02215

A Phase 1 clinical study for patients using PART 1: PT2385 Tablets and PART 2: PT2385 Tablets in combination with nivolumab

Boston Massachusetts 02215

A Phase 1 clinical study for patients using PART 1: PT2385 Tablets and PART 2: PT2385 Tablets in combination with nivolumab

Boston Massachusetts 02114

A Phase 1 clinical study for patients with Neoplasms, Advanced Solid Tumors

Boston Massachusetts 02215

A Phase 1 clinical study for patients with Neoplasms, Advanced Solid Tumors

Boston Massachusetts 02215

A Phase 1 clinical study for patients with Neoplasms, Advanced Solid Tumors

Boston Massachusetts 02115

A Phase 1 clinical study for patients with Neoplasms, Advanced Solid Tumors